Benitec Biopharma (BNTC) Other Working Capital Changes (2019 - 2025)
Benitec Biopharma (BNTC) reported Other Working Capital Changes of $195000.0 for Q4 2025, up 400.0% on a YoY basis from $39000.0 in Q4 2024, and up 225.0% sequentially from -$156000.0 in Q3 2025.
Benitec Biopharma (BNTC) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Other Working Capital Changes data on file, last reported at $195000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 400.0% year-over-year to $195000.0; the trailing twelve-month figure through Dec 2025 stood at $315000.0 (up 775.0% YoY), and the FY2025 full-year result was $111000.0, up 117.21% from the prior year.
- Other Working Capital Changes rose to $195000.0 in Q4 2025, from -$156000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $547000.0 in Q2 2022 to a low of -$709000.0 in Q3 2023.
- A 5-year average of $14250.0 and a median of -$82500.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes slumped 482.0% in 2021 and soared 400.0% in 2025, its largest moves.
- Tracing BNTC's Other Working Capital Changes over 5 years: stood at -$291000.0 in 2021, then soared by 42.27% to -$168000.0 in 2022, then advanced by 18.45% to -$137000.0 in 2023, then soared by 52.55% to -$65000.0 in 2024, then soared by 400.0% to $195000.0 in 2025.
- Business Quant data shows BNTC's Other Working Capital Changes at $195000.0 in Q4 2025, -$156000.0 in Q3 2025, and $258000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 195,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Jun 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 258,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 406,000.00 |